INTRODUCTION

Hydatid cyst is an endemic disease in Iran and other
Middle East countries. The lung is the second most common organ after liver that is involved in this parasitic disease. Although there are some controversies about the optimal therapeutic strategy for patients with pulmonary hydatid cyst, most of the investigators believe that surgery is the best therapy. Albendazole has been used as a prophylactic drug before surgery for reducing recurrence or as a definitive medical therapy in patients with this disease. Some physician uses this drug as a sole treatment for pulmonary hydatid cyst especially in patients who are not a good candidate for surgery (1) (2) (3) . On the other hand, clinical observations have shown an increased incidence of spontaneous rupture of lung cysts following administration of albendazole. In this case report, we present a patient with multiple hydatid cysts in liver and lungs that had been treated with albendazole but his clinical course became grave due to rupturing of the pulmonary cysts and terminated with the death of the patient.
CASE SUMMARY
A 43-years-old man was admitted to the emergency room due to severe cough, fever, vomiting and copious sputum production. Physical examination at arrival revealed tachypnea and bilaterally diminished breath sounds. Nine months before this event, the patient was visited by a physician due to right flank pain and based on the detection of a large cystic lesion on liver sonography, the diagnosis of hydatid cyst was made. At that time bilateral pulmonary hydatid cysts were discovered on chest X-ray that was approved by CT scan (Figure 1 ).
Thoracotomy and resection of the pulmonary cyst were planned for treating the lung cysts and preoperative albendazole was begun with the dose of 400 mg twice Again, after four days with worsening of respiratory symptoms and respiratory failure the patient was intubated and placed on mechanical ventilation (sixteenth day after admission), however due to the progression of the infectious process and severe sepsis, the patient died. this therapeutic effect will appear after at least ten days following administration of this drug (11, 12) .
According to increased incidence of pulmonary hydatid cyst rupture following albendazole therapy and not fully recognized effect of the drug in reducing recurrence rate, it is probable that the best-justified policy in the treatment of pulmonary hydatid cyst is immediate surgical evacuation without any further albendazole prophylaxis.
CONCLUSION
Albendazole has been used as a prophylactic treatment before surgery in patients with pulmonary hydatid cyst for reducing recurrence rate. This drug can cause spontaneous rupture of cysts with some unpredictable complications.
Although rupture of cyst can occur in the absence of albendazole treatment we believe that this drug is a potential cause and more investigations are needed to prove it clinically. Therefore, we believe early surgical treatment even without albendazole prophylaxis provides an acceptable strategy for treating these patients.
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